Complete remission of cutaneous and subcutaneous melanoma metastases of the scalp with imiquimod therapy: Case Reports;Vollständige Remission multipler kutaner und subkutaner Melanommetastasen am Kapillitium unter Therapie mit Imiquimod

JDDG - Journal of the German Society of Dermatology

Volumn 7, Issue 6, 2009, Pages 534-536

  Heber, Giada ^a   Helbig, Doris ^a   Pönitzsch, Iris ^a   Wetzig, Tino ^a   Harth, Wolfgang ^b   Simon, Jan Christoph ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b Vivantes Clinic in Friedrichshain   (Germany)

Author keywords

Imiquimod; Immune therapy; Melanoma

Indexed keywords

IMIQUIMOD; LACTATE DEHYDROGENASE; PROTEIN S 100;

ADULT; APPLICATION SITE BURNING; ARTICLE; CANCER CHEMOTHERAPY; CANCER REGRESSION; CANCER STAGING; CANCER SURGERY; CASE REPORT; EROSION; ERYTHEMA; HUMAN; HUMAN TISSUE; IMMUNOMODULATION; IMMUNOTHERAPY; LYMPH NODE METASTASIS; MALE; MELANOMA; METASTASIS; PRIMARY TUMOR; PRURITUS; REMISSION; SKIN BIOPSY; SKIN METASTASIS; THORAX RADIOGRAPHY; TREATMENT DURATION; ULTRASOUND; VISCERAL METASTASIS;

EID: 67449138767     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2009.07038.x     Document Type: Article

References (15)

1. Terheyden P, Kortüm AK, Schulze HJ, Durani B, Remling R, Mauch C, Junghans V, Schadendorf D, Beiteke U, Jünger M, Becker JC, Bröcker EB. Chemoimmunotherapy for cutaneous melanoma with dacarbazine and epifocal contact sensitizers: results of a nationwide survey for the German Dermatologic Co-operative Oncology Group. J Cancer Res Clin Oncol 2007 133 (7 437 444. (Pubitemid 46800664)
2. von Wussow P, Block B, Hartmann F, Deicher H. Intralesional Interferon-alpha therapy in advanced malignant melanoma. Cancer 1988 61 (6 1071 1074. (Pubitemid 18078593)
3. Radny P, Caroli UM, Bauer J, Paul T, Schlegel C, Eigentler TK, Weide B, Schwarz M, Garbe C. Phase II trial of intralesional therapy with interleukin-2 in soft tissue melanoma metastases. Br J Cancer 2003 89 : 1620 1626. (Pubitemid 37464130)
4. Suckow M, Haller S, Ott A, Baum HP, Pönnighaus JM, Kowalzick L. Behandlung multipler kutaner Melanommetastasen des Gesichts mit intratumoralen Beta-Interferon-Injektionen. Aktuelle Dermatologie 2000 26 : 235 237.
5. Bong AB, Bonnekoh B, Franke I, Schön MP, Ulrich J, Gollnick H. Imiquimod, a topical immune response modifier, in the treatment of cutaneous metastases of malignant melanoma. Dermatology 2002 205 : 135 138.
6. Steinmann A, Funk JO, Schuler G, von den Driesch P. Topical imiquimod treatment of a cutaneous melanoma metastasis. J Am Acad Dermatol 2000 43 : 555 556. (Pubitemid 30666755)
7. Wolf IH, Smolle J, Binder B, Cerroni L, Richtig E, Kerl H. Topical imiquimod in the treatment of metastatic melanoma to skin. Arch Dermatol 2003 139 : 273 276. (Pubitemid 36330572)
8. Green DS, Bodman-Smith MD, Dalgleish AG, Fischer MD. Phase I/II study of topical imiquimod and intralesional interleukin-2 in the treatment of accessible metastases in malignant melanoma. Br J Dermatol 2007 156 (2 337 345. (Pubitemid 46095963)
9. Loquai C, Nashan D, Metze D, Beiteke U, Rüping KW, Luger TA, Grabbe S. Imiquimod, pegylated interferon-alpha-2b and interleukin-2 in the treatment of cutaneous melanoma metastases. Hautarzt 2004 55 (2 176 181. (Pubitemid 38391406)
10. Stanley MA. Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential. Clin Exp Dermatol 2002 27 (7 571 577. (Pubitemid 35463873)
11. Navi D, Huntley A. Imiquimod 5 percent cream and the treatment of cutaneous malignancy. Dermatol Online J 10 (1 4. (Pubitemid 39383767)
12. Skinner RB. Imiquimod. Dermatol Clin 2003 21 (2 291 300. (Pubitemid 36529763)
13. Schön M, Bong AB, Drewniok C, Herz J, Geilen CC, Reifenberger J, Benninghoff B, Slade HB, Gollnick H, Schön MP. Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod. J Natl Cancer Inst 2003 95 (15 1138 1149. (Pubitemid 37045392)
14. Majewski S, Marczak M, Mlynarczyk B, Benninghoff B, Jablonska S. Imiquimod is a strong inhibitor of tumor-cell induced angiogenesis. Int J Dermatol 2005 44 (1 14 19. (Pubitemid 40201982)
15. Beutner KR, Geisse JK, Helman D, Fox TL, Ginkel A, Owens ML. Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream. J Am Acad Dermatol 1999 41 (6 1002 1007.